Company intelligence / Profile preview

Oryx Horn

Ownership: Private
Development stage: Other

Overview

Oryx Horn is a private investment firm providing growth capital to healthcare service businesses with $1–5 million EBITDA. The firm specializes in supporting management teams and founders to accelerate business growth through operational expertise in physician-constrained specialties. It does not develop drugs or own clinical-stage assets but focuses on scaling healthcare operations post-acquisition.

Therapeutic areas: OtherPsychiatryNeurologyWomen's Health
Industry: Investors

Partnerships

Recruiting partnerships for business analysis and physician support; no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Oryx Horn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oryx Horn.

Explore the full profile